de Mari M - Search Results

1

Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias.

Zoccolella S, Lamberti P, Iliceto G, Dell'Aquila C, Diroma C, Fraddosio A, Lamberti SV, Armenise E, Defazio G, de Mari M, Livrea P. Zoccolella S, et al. Among authors: de mari m. Clin Chem Lab Med. 2006;44(7):863-6. doi: 10.1515/CCLM.2006.143. Clin Chem Lab Med. 2006. PMID: 16776634

2

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.

Lamberti P, Zoccolella S, Iliceto G, Armenise E, Fraddosio A, de Mari M, Livrea P. Lamberti P, et al. Among authors: de mari m. Mov Disord. 2005 Jan;20(1):69-72. doi: 10.1002/mds.20261. Mov Disord. 2005. PMID: 15390046 Clinical Trial.

3

Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.

Zoccolella S, Lamberti P, Iliceto G, Diroma C, Armenise E, Defazio G, Lamberti SV, Fraddosio A, de Mari M, Livrea P. Zoccolella S, et al. Among authors: de mari m. Clin Chem Lab Med. 2005;43(10):1107-10. doi: 10.1515/CCLM.2005.193. Clin Chem Lab Med. 2005. PMID: 16197306

4

Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.

Zoccolella S, Iliceto G, deMari M, Livrea P, Lamberti P. Zoccolella S, et al. Clin Chem Lab Med. 2007;45(12):1607-13. doi: 10.1515/CCLM.2007.337. Clin Chem Lab Med. 2007. PMID: 17963454 Review.

5

Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?

Lamberti P, de Mari M, Iliceto G, Federico F. Lamberti P, et al. Among authors: de mari m. Acta Neurol (Napoli). 1992 Aug-Dec;14(4-6):451-4. Acta Neurol (Napoli). 1992. PMID: 1293988

6

Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications.

Zoccolella S, Lamberti P, Armenise E, de Mari M, Lamberti SV, Mastronardi R, Fraddosio A, Iliceto G, Livrea P. Zoccolella S, et al. Among authors: de mari m. Parkinsonism Relat Disord. 2005 Mar;11(2):131-3. doi: 10.1016/j.parkreldis.2004.07.008. Epub 2004 Dec 20. Parkinsonism Relat Disord. 2005. PMID: 15734674 Clinical Trial.

7

Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.

Lamberti P, Zoccolella S, Armenise E, Lamberti SV, Fraddosio A, de Mari M, Iliceto G, Livrea P. Lamberti P, et al. Among authors: de mari m. Eur J Neurol. 2005 May;12(5):365-8. doi: 10.1111/j.1468-1331.2004.00973.x. Eur J Neurol. 2005. PMID: 15804266

8

Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.

dell'Aquila C, Zoccolella S, Cardinali V, de Mari M, Iliceto G, Tartaglione B, Lamberti P, Logroscino G. dell'Aquila C, et al. Among authors: de mari m. Parkinsonism Relat Disord. 2013 Nov;19(11):980-5. doi: 10.1016/j.parkreldis.2013.06.014. Epub 2013 Aug 19. Parkinsonism Relat Disord. 2013. PMID: 23968651

9

Effect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia.

Lamberti P, de Mari M, Iliceto G, Caldarola M, Serlenga L. Lamberti P, et al. Among authors: de mari m. Mov Disord. 1993 Apr;8(2):236-7. doi: 10.1002/mds.870080228. Mov Disord. 1993. PMID: 8474501 No abstract available.

10

Freezing gait in Parkinson's disease.

Lamberti P, Armenise S, Castaldo V, de Mari M, Iliceto G, Tronci P, Serlenga L. Lamberti P, et al. Among authors: de mari m. Eur Neurol. 1997;38(4):297-301. doi: 10.1159/000113398. Eur Neurol. 1997. PMID: 9434089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters